Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.
Read the full story at ScienceDaily Health →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.

